About Shree Anand Life Sciences Limited
Data last updated:
Shree Anand Life Sciences Limited is a public limited company based in Belgaum, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 November 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2006PLC040855. Its GSTIN is 29AALCS6361E1Z1 (Karnataka).
The company has an authorised share capital of ₹24 Cr and a paid-up capital of ₹14.61 Cr. It was formerly known as Shree Anand Life Sciences Private Limited. It is led by directors including Satish Mohanrao Gharge (Managing Director) and Sanjay Mohanrao Gharge.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Sy. No. 536 Plot No. 63/A & B Honaga Industrial Area Honaga, Belgaum, Karnataka, India – 591113.
As per the financials filed for FY 2023, the company reported a revenue of ₹40.42 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹29.75 Cr (net margin -73.6%) and EBITDA of -₹62.84 Lakh (EBITDA margin -1.6%). Revenue has grown at a compounded annual rate (CAGR) of 104% over three years and 267% over five years.
The company has about 156 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Shree Anand Life Sciences. As per MCA filings, the company has open charges of ₹94.32 Cr and satisfied charges of ₹36.54 Cr on record. Court records list 25 cases involving the company, including 11 filed by the company and 14 filed against it; 13 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website salsl.com.
Company details
CIN history
Shree Anand Life Sciences has one previous CIN (Corporate Identification Number): U24232KA2006PTC040855. The current CIN is U24232KA2006PLC040855, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232KA2006PLC040855 | Current |
| U24232KA2006PTC040855 | Previous |
Contact details
Shree Anand Life Sciences Limited's registered office is in Belgaum, Karnataka. Its website is salsl.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSy. No. 536 Plot No. 63/A & B Honaga Industrial Area Honaga, Belgaum, Karnataka, India – 591113
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shree Anand Life Sciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Shree Anand Life Sciences operates one associated brand: Shree Anand Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of pharmaceutical injections and healthcare products in India. | salsl.com |
Business activity
The main business activity of Shree Anand Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shree Anand Life Sciences Limited, buy the company report.
Financials of Shree Anand Life Sciences Limited
FY 2023 filings availableShree Anand Life Sciences Limited reported revenue of ₹40.42 Cr (down 2% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 267%. EBITDA rose 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹40.42 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹62.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹29.75 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.6% | ||||
| Net Profit Margin | -73.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shree Anand Life Sciences Limited, buy the company report.
Board of directors of Shree Anand Life Sciences Limited
Shree Anand Life Sciences has 5 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Mohanrao Gharge Also directs: Sapnanand Life Science Limited | Managing Director | 06 Nov 2006 | 19 Years 11 Months | Current |
| Sanjay Mohanrao Gharge | Director | 06 Nov 2006 | 19 Years 11 Months | Current |
| Gharge Asha Satish | Director | 06 Nov 2006 | 19 Years 11 Months | Current |
| Virendra Shashikant Pawar | Director | 09 Sep 2015 | 11 Years 1 Months | Current |
| Aishwarya Satish Gharge | Director | 12 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Shree Anand Life Sciences Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mefro Organic Limited | ₹40.54 Cr (FY 2025) | -8.0% | Mohali, Punjab, India | |||
| Divine Laboratories Pvt. Ltd. | ₹40.5 Cr (FY 2025) | 13.0% | Vadodara, Gujarat, India | |||
| Viridis Biopharma Private Limited | ₹40.48 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Shree Anand Life Sciences Limitedthis company | ₹40.42 Cr (FY 2023) | -₹29.75 Cr | -73.6% | -2.0% | 156 | Belgaum, Karnataka, India |
| Alas Pharmaceuticals Private Limited | ₹40.4 Cr (FY 2021) | Pune, Maharashtra, India | ||||
| Yacca Pharmaceuticals Private Limited | ₹40.38 Cr (FY 2024) | 6.0% | Uttar Pradesh, India | |||
| Vindas Chemical Industries Private Limited | ₹40.36 Cr (FY 2025) | 74.0% | Dhar, Madhya Pradesh, India | |||
| Alkimia Pharma-Chem Private Limited | ₹40.2 Cr (FY 2025) | 975.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Shree Anand Life Sciences Limited, buy the company report.
Auditor
Shree Anand Life Sciences Limited is audited by M/s.Pavan R Pujari & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s.Pavan R Pujari & Co | FY 2023 |
Shareholding
The shareholding of Shree Anand Life Sciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shree Anand Life Sciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2022 | 100595314 | Others | ₹9 Cr | Open | |
| 01 Dec 2021 | 100524359 | Hdfc Bank Limited | ₹32 Lakh | Open | |
| 26 Apr 2017 | 100255471 | Others | ₹85 Cr | Open | |
| 27 Dec 2010 | 10268241 | Bank of India | ₹26.08 Cr | Satisfied | |
| 24 Dec 2010 | 10265931 | Bank of India | ₹7.96 Cr | Satisfied |
To see the full charge records of Shree Anand Life Sciences Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Shree Anand Life Sciences Limited has 25 court cases on record: 11 filed by Shree Anand Life Sciences, 14 filed against it. 13 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 15 | 14 | 12 |
| High courts | 10 | 0 | 1 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nashik, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by Borosil Scientific Limited Trough Chandrashekhar Balkrishna Chitnis | Pending |
| District court, Pune, Maharashtra | Court case (Spl.Sum.Suit) | Filed against the company by Eugen Printing and Packaging Private Limited Through Authorised Signatory Pradyumna Kulkarni | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by Bharat Rubber Works Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case SC) | Filed against the company by Aquatic Remedies Limited | Pending |
| District court, BELAGAVI, Karnataka | Execution petition | Filed against the company by M/S. Impressions, A Partnership Firm, R/By Its Partner, Ashok Pandurang Dhond | Pending |
To see the full case history of Shree Anand Life Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shree Anand Life Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Shree Anand Life Sciences Limited has a workforce of 156 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Shree Anand Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AALCS6361E1Z1 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shree Anand Life Sciences Limited, buy the company report.
Recent activity
Shree Anand Life Sciences Limited has 15 board changes on record since 2006: 5 appointments and 10 cessations. The latest: Sunil Mohan Potdar ceased to be Director on 11 Jul 2019.
16 earlier events are in the company report.
Frequently asked questions
Shree Anand Life Sciences is an active public limited company based in Belgaum, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 November 2006 (20+ years old) and is registered under CIN U24232KA2006PLC040855.
Shree Anand Life Sciences has 5 current directors:
- Satish Mohanrao Gharge - Managing Director
- Sanjay Mohanrao Gharge - Director
- Gharge Asha Satish - Director
- Virendra Shashikant Pawar - Director
- Aishwarya Satish Gharge - Director
The latest financial statements of Shree Anand Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Shree Anand Life Sciences is 29AALCS6361E1Z1, registered in Karnataka.
The CIN (Corporate Identification Number) of Shree Anand Life Sciences is U24232KA2006PLC040855. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shree Anand Life Sciences has 25 court cases on record: 11 filed by the company and 14 filed against it. 13 are pending. Most are in the district courts.
Shree Anand Life Sciences was incorporated on 06 November 2006, making it 20+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Shree Anand Life Sciences by revenue are Mefro Organic Limited, Divine Laboratories Pvt. Ltd, Viridis Biopharma Private Limited, Alas Pharmaceuticals Private Limited, Yacca Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sunil Mohan Potdar ceased to be Director on 11 Jul 2019. Aishwarya Satish Gharge ceased to be Additional Director on 29 Sep 2018. Aishwarya Satish Gharge was appointed as Director on 12 Mar 2018. Shree Anand Life Sciences has 15 board changes on record in total.
Shree Anand Life Sciences can be reached through the website salsl.com. Its registered office is in Belgaum, Karnataka, India.
The registered office of Shree Anand Life Sciences is at Sy. No. 536 Plot No. 63A & B Honaga Industrial Area Honaga, Belgaum, Karnataka, India – 591113.